Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice

被引:45
作者
Yan, Ying
Cook, Julie
McQuillan, Jay
Zhang, Guifang
Hitzman, Cory J.
Wang, Yian
Wiedmann, Timothy S.
You, Ming
机构
[1] Washington Univ, Dept Surg, Alvin J Siteman Canc Ctr, Sch Med, St Louis, MO 63110 USA
[2] Univ Minnesota, Dept Pharmaceut, Minneapolis, MN 55455 USA
来源
NEOPLASIA | 2007年 / 9卷 / 05期
关键词
aerosol; polyphenon E; mouse; lung tumorigenesis; chemoprevention;
D O I
10.1593/neo.07160
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Effective chemoprevention of lung cancer in high- risk patients through the administration of pharmacologic or nutritional agents is urgently needed. Aerosol inhalation can deliver chemopreventive agents directly to the respiratory tract to inhibit the tumorigenic process. In this study, polyphenon E ( PolyE) and (-)epigallocatechin- 3- gallate ( EGCG) were administered by aerosol delivery to A/ J mice beginning 2 weeks after carcinogen treatment and continuing daily by inhalation throughout the remainder of the study ( 20 weeks). PolyE decreased tumor load by similar to 59%. However, EGCG, both at the same dose and at a higher dose, failed to inhibit lung carcinogenesis. These results indicate that aerosol delivery of PolyE, but not EGCG, may be a useful chemopreventive protocol in subjects at high risk for lung cancer.
引用
收藏
页码:401 / 405
页数:5
相关论文
共 27 条
[11]   (-)-epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice [J].
Mimoto, J ;
Kiura, K ;
Matsuo, K ;
Yoshino, T ;
Takata, I ;
Ueoka, H ;
Kataoka, M ;
Harada, M .
CARCINOGENESIS, 2000, 21 (05) :915-919
[12]   Focus on lung cancer [J].
Minna, JD ;
Roth, JA ;
Gazdar, AF .
CANCER CELL, 2002, 1 (01) :49-52
[13]   Aerosol Therapy for Malignancy Involving the Lungs [J].
Rao, R. D. ;
Markovic, S. N. ;
Anderson, P. M. .
CURRENT CANCER DRUG TARGETS, 2003, 3 (04) :239-250
[14]   (-)-epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells [J].
Shimizu, M ;
Deguchi, A ;
Lim, JTE ;
Moriwaki, H ;
Kopelovich, L ;
Weinstein, IB .
CLINICAL CANCER RESEARCH, 2005, 11 (07) :2735-2746
[15]   FURTHER STUDY OF NEBULIZATION CHEMOTHERAPY, A NEW CHEMOTHERAPEUTIC METHOD IN THE TREATMENT OF LUNG CARCINOMAS - FUNDAMENTAL AND CLINICAL [J].
TATSUMURA, T ;
KOYAMA, S ;
TSUJIMOTO, M ;
KITAGAWA, M ;
KAGAMIMORI, S .
BRITISH JOURNAL OF CANCER, 1993, 68 (06) :1146-1149
[16]   Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced pulmonary malignancies [J].
Verschraegen, CF ;
Gilbert, BE ;
Loyer, E ;
Huaringa, A ;
Walsh, G ;
Newman, RA ;
Knight, V .
CLINICAL CANCER RESEARCH, 2004, 10 (07) :2319-2326
[17]  
WANG ZY, 1992, CANCER RES, V52, P1943
[18]  
WANG ZY, 1992, CANCER RES, V52, P6657
[19]  
Wattenberg LW, 1997, CANCER RES, V57, P5489
[20]   Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol [J].
Wattenberg, LW ;
Wiedmann, TS ;
Estensen, RD ;
Zimmerman, CL ;
Galbraith, AR ;
Steele, VE ;
Kelloff, GJ .
CARCINOGENESIS, 2000, 21 (02) :179-182